Abiomed is a medical device company that specializes in the development and commercialization of devices that assist or replace the pumping function of the failing heart. The company's most notable product is the Impella heart pump, which is a small device that is inserted into a patient's heart through a catheter and is used to support blood flow in people who are experiencing heart failure or other cardiac conditions.
The Impella device is inserted through a small incision in the patient's leg and navigated to the heart through the bloodstream. Once in place, it can be used to take over the pumping function of the heart, allowing it to rest and recover. Impella is used in a wide range of cardiac procedures, including heart attack treatment, heart failure treatment, and elective and urgent percutaneous coronary interventions (PCI).
Abiomed is also researching and developing other devices to assist or replace the heart, such as total artificial hearts, ventricular assist devices and other circulatory support technologies.
Abiomed is publicly traded company listed in the NASDAQ stock exchange and headquartered in Danvers, Massachusetts, USA.